MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,479,000 | -6.1% | 18,165 | -30.4% | 0.06% | -6.2% |
| Q2 2016 | $1,575,000 | +1.7% | 26,115 | -22.4% | 0.06% | +1.6% |
| Q1 2016 | $1,548,000 | -19.7% | 33,670 | -15.5% | 0.06% | -17.1% |
| Q4 2015 | $1,927,000 | -0.4% | 39,860 | -12.4% | 0.08% | +1.3% |
| Q3 2015 | $1,935,000 | -37.5% | 45,526 | +68.0% | 0.08% | -26.5% |
| Q2 2015 | $3,095,000 | -13.1% | 27,100 | -1.8% | 0.10% | -11.3% |
| Q1 2015 | $3,560,000 | +33.1% | 27,585 | +2.7% | 0.12% | +32.2% |
| Q4 2014 | $2,675,000 | – | 26,850 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |